The number on your lab report looks precise, official, and final - but without the right context, it can be almost meaningless
The option to continue or initiate treatment with approved AD medications during the trial, including cholinesterase inhibitors and recently approved anti-amyloid monoclonal antibody treatments that may be available during trial execution, will allow for important information to be gathered on the safety of concurrent use of these medications with different mechanisms of action and provides flexibility in an evolving therapeutic landscape
It is important to note that patients in this study were treated for GERD with 40 mg omeprazole for at least three months prior to sampling of gastric contents, while the control group, which also had symptoms of GERD similar to the experimental group, was restricted from utilizing acid-suppressing medications for at least two weeks prior to examination of gastric contents (Theisen 2000)
A trial of omarigliptin evaluated 4202 diabetic patients without acute ischemic disease, who were followed for a median of 1.8 years, before early termination of the trial [50]